MEDX 📈 Horizon Kinetics Medical - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US53656G5633 • Health
MEDX: Biotech, Pharmaceuticals, Medical Equipment, Medical Devices, Healthcare
The fund is an actively-managed exchange-traded fund ('ETF') that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.
Additional Sources for MEDX ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MEDX ETF Overview
| Market Cap in USD | 16m |
| Category | Health |
| TER | 0.85% |
| IPO / Inception | 1999-09-30 |
MEDX ETF Ratings
| Growth 5y | -26.0% |
| Fundamental | - |
| Dividend | 29.3% |
| Rel. Strength Industry | -105 |
| Analysts | - |
| Fair Price Momentum | 23.96 USD |
| Fair Price DCF | - |
MEDX Dividends
| Dividend Yield 12m | 6.10% |
| Yield on Cost 5y | 5.51% |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
MEDX Growth Ratios
| Growth Correlation 3m | -88.6% |
| Growth Correlation 12m | 23.5% |
| Growth Correlation 5y | 25.3% |
| CAGR 5y | -5.13% |
| CAGR/Mean DD 5y | -0.94 |
| Sharpe Ratio 12m | -0.50 |
| Alpha | -23.62 |
| Beta | 0.73 |
| Volatility | 17.17% |
| Current Volume | 2k |
| Average Volume 20d | 2.5k |
What is the price of MEDX stocks?
As of December 22, 2024, the stock is trading at USD 26.94 with a total of 2,000 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -1.14%, over three months by -13.85% and over the past year by -1.41%.
As of December 22, 2024, the stock is trading at USD 26.94 with a total of 2,000 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -1.14%, over three months by -13.85% and over the past year by -1.41%.
Is Horizon Kinetics Medical a good stock to buy?
Probably not. Based on ValueRay Analyses, Horizon Kinetics Medical (NASDAQ:MEDX) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -26.01 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MEDX as of December 2024 is 23.96. This means that MEDX is currently overvalued and has a potential downside of -11.06%.
Probably not. Based on ValueRay Analyses, Horizon Kinetics Medical (NASDAQ:MEDX) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -26.01 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MEDX as of December 2024 is 23.96. This means that MEDX is currently overvalued and has a potential downside of -11.06%.
Is MEDX a buy, sell or hold?
Horizon Kinetics Medical has no consensus analysts rating.
Horizon Kinetics Medical has no consensus analysts rating.
What are the forecast for MEDX stock price target?
According to ValueRays Forecast Model, MEDX Horizon Kinetics Medical will be worth about 26.4 in December 2025. The stock is currently trading at 26.94. This means that the stock has a potential downside of -1.93%.
According to ValueRays Forecast Model, MEDX Horizon Kinetics Medical will be worth about 26.4 in December 2025. The stock is currently trading at 26.94. This means that the stock has a potential downside of -1.93%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.4 | -1.9% |